Your browser doesn't support javascript.
loading
Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells.
Pfankuchen, Daniel Bastian; Stölting, Daniel Philipp; Schlesinger, Martin; Royer, Hans-Dieter; Bendas, Gerd.
Afiliação
  • Pfankuchen DB; Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-University Bonn, An der Immenburg 4, 53121 Bonn, Germany. Electronic address: s6dapfan@uni-bonn.de.
  • Stölting DP; Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-University Bonn, An der Immenburg 4, 53121 Bonn, Germany. Electronic address: dastoelt@uni-bonn.de.
  • Schlesinger M; Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-University Bonn, An der Immenburg 4, 53121 Bonn, Germany. Electronic address: mschlesi@uni-bonn.de.
  • Royer HD; Institute of Human Genetics and Anthropology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Universitätsstr.1, 40225 Düsseldorf, Germany. Electronic address: Hans-Dieter.Royer@uni-duesseldorf.de.
  • Bendas G; Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-University Bonn, An der Immenburg 4, 53121 Bonn, Germany. Electronic address: gbendas@uni-bonn.de.
Biochem Pharmacol ; 97(2): 147-57, 2015 Sep 15.
Article em En | MEDLINE | ID: mdl-26239805

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / Heparina de Baixo Peso Molecular / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / Heparina de Baixo Peso Molecular / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article